Litha Healthcare Group Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Litha Healthcare Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014386
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. The company operates through its three divisions such as pharmaceuticals, medical devices and biotechnology. Its pharma division offers generic, originator and complementary medicines in the therapeutic areas of oncology, gastroenterology, neurology, urology and dermatology, among others. Litha Healthcare provides medical devices, consumables and equipment serving the therapeutic areas of ophthalmology, orthopaedics and sports medicine, surgery and others. Litha Healthcare’s biotechnology division manufactures and research and development of human vaccines. The company also has international partnerships with several pharmaceutical and medical companies and institutes. Litha Healthcare is headquartered in Midrand, South Africa.

Litha Healthcare Group Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Litha Healthcare Group Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 11
Partnerships 12
Litha Pharma Partners with Gland Pharma 12
Litha Pharma Partners with NTC 13
Litha Healthcare Enters Into Co-Development Agreement With Micro Labs 14
Litha Pharma Partners with Natco Pharma 15
Licensing Agreements 16
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 16
Asset Transactions 17
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 17
Acquisition 18
Acino Pharma Acquires Litha Healthcare from Endo International 18
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 20
Litha Healthcare Acquires OTC Pharma South Africa 21
Litha Healthcare Acquires Goldex Healthcare For US$4 Million 22
Litha Healthcare Group Ltd – Key Competitors 23
Litha Healthcare Group Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Litha Healthcare Group Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Litha Healthcare Group Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 11
Litha Pharma Partners with Gland Pharma 12
Litha Pharma Partners with NTC 13
Litha Healthcare Enters Into Co-Development Agreement With Micro Labs 14
Litha Pharma Partners with Natco Pharma 15
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 16
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 17
Acino Pharma Acquires Litha Healthcare from Endo International 18
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 20
Litha Healthcare Acquires OTC Pharma South Africa 21
Litha Healthcare Acquires Goldex Healthcare For US$4 Million 22
Litha Healthcare Group Ltd, Key Competitors 23
Litha Healthcare Group Ltd, Subsidiaries 24

★海外企業調査レポート[Litha Healthcare Group Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CDW Corporation:戦略・SWOT・企業財務分析
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • 3i Group Plc:企業のM&A・事業提携・投資動向
    3i Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3i Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Nuverra Environmental Solutions Inc (NES):石油・ガス:M&Aディール及び事業提携情報
    Summary Nuverra Environmental Solutions Inc (Nuverra), formerly Heckmann Corporation, provides environmental solutions to customers focused on the development and ongoing production of oil and natural gas from shale formations. It provides environmental solutions, including delivery, collection, tre …
  • Aprima Medical Software Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aprima Medical Software Inc (Aprima) is a healthcare information technology service provider. The company’s solutions include EHR, practice management, and revenue cycle management. Its EHR solutions provide patient engagement, mobility, clinical decision support, integrated inbound and outb …
  • Lake Region Electric Cooperative Inc:企業の戦略的SWOT分析
    Lake Region Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Vertex Pharmaceuticals Inc (VRTX):企業の財務・戦略的SWOT分析
    Vertex Pharmaceuticals Inc (VRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • 3E sanv:企業の戦略的SWOT分析
    3E sanv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Club Mediterranee SA:戦略・SWOT・企業財務分析
    Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report Summary Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GVC Holdings PLC:戦略・SWOT・企業財務分析
    GVC Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary GVC Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Intra Energy Corporation Ltd (IEC):電力:M&Aディール及び事業提携情報
    Summary Intra Energy Corporation Limited (IEC), formerly Atomic Resources Limited, is a mining and energy company that operates through subsidiaries, affiliates, and joint ventures. It explores and mines coal, mineral resources, ore reserves, and uranium through operating interests in various mines. …
  • General Electric Co (GE)-石油・ガス分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Piramal Glass Ltd:企業の戦略・SWOT・財務情報
    Piramal Glass Ltd - Strategy, SWOT and Corporate Finance Report Summary Piramal Glass Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Knight-Swift Transportation Holdings Inc (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • The Credit Mutuel-Cic Group
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Response Biomedical Corp-医療機器分野:企業M&A・提携分析
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …
  • Oceania Cruises, Inc.:企業の戦略・SWOT・財務分析
    Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Development Bank of Japan Inc:企業のM&A・事業提携・投資動向
    Development Bank of Japan Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Development Bank of Japan Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • IV Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary IV Diagnostics Inc (IV Diagnostics) is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. …
  • XCyton Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary XCyton Diagnostics Ltd (Xcyton) is a molecular biology company that develops and markets diagnostics products and services. The company provides ELISA kit for the detection of HIV infection; ELISA products for the detection of Neurocysticercosis, Hepatitis C and Japanese encephalitis. It pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆